Viral Pneumonia

25 registered clinical trials studyying Viral Pneumonia — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of N NCT07386912	Research Center Borstel	—
Recruiting	Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection NCT06999603	Synairgen Research Ltd.	Phase 2
Active Not Recruiting	Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Fact NCT07238114	Universitaire Ziekenhuizen KU Leuven	—
Recruiting	Mucosal Associated Invariant T Cell During Viral Pneumonia and Acute Respiratory Distress Syndrome NCT06720818	University Hospital, Tours	—
Withdrawn	Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias NCT05286255	Medical University of South Carolina	Phase 1
Completed	Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic NCT06349707	Central Hospital, Nancy, France	—
Terminated	Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia NCT05531149	Biotest	Phase 3
Unknown	Yinhu Qingwen Granule in the Treatment of Viral Pneumonia NCT04955223	Zhong Wang	EARLY_Phase 1
Unknown	Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort Study NCT05612893	Capital Medical University	—
Unknown	Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19 NCT04876573	Ciusss de L'Est de l'Île de Montréal	Phase 2
Unknown	Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial NCT04820751	Ciusss de L'Est de l'Île de Montréal	Phase 3
Completed	Inhaled NO for the Treatment of Viral Pneumonia in Adults NCT04606407	Beyond Air Inc.	N/A
Unknown	Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID NCT04952337	Hannover Medical School	—
Unknown	Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19) NCT04397497	Ospedale San Raffaele	Phase 2
Terminated	Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia NCT04345289	Thomas Benfield	Phase 3
Unknown	Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia NCT04380376	Federal State Budgetary Institution, Pulmonology Scientific Research Institute	Phase 2
Completed	Study of the Use of the Drug Ingaron in Patients With COVID-19 NCT05386459	SPP Pharmaclon Ltd.	—
Completed	Imaging Feature of SARS-CoV2 Infection NCT04394026	Francesco De Cobelli	—
Unknown	Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection NCT04326036	Black Tie Medical, Inc.	EARLY_Phase 1
Completed	Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure NCT04385823	Hôpital Louis Mourier	—
Completed	Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis NCT04644302	University Hospital Hradec Kralove	—
Completed	PTH - Preemptive Treatment for Herpesviridae NCT02152358	Assistance Publique Hopitaux De Marseille	Phase 4
Completed	Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial NCT01868113	Makerere University	Phase 3
Unknown	A Registry Study on Xiyanping(a Chinese Medicine Injection) Used in Fifty Hospitals NCT01612572	China Academy of Chinese Medical Sciences	—
Withdrawn	Use of TREM-1 Protein to Differentiate Viral and Bacterial Pneumonias in Intubated Children NCT00645619	University of Texas Southwestern Medical Center	—